Ro48-8684: Difference between revisions
Appearance
Content deleted Content added
Updating {{drugbox}} (no changed fields - added verified revid - updated 'ChemSpiderID_Ref', 'UNII_Ref', 'ChEMBL_Ref', 'ChEBI_Ref', 'KEGG_Ref', 'StdInChI_Ref', 'StdInChIKey_Ref', 'ChEBI_Ref') per Chem/Drugbox validation (report [[Wik |
CAS from https://synapse.patsnap.com/drug/8792804560a54d75872c5c6c350a4fac |
||
(14 intermediate revisions by 14 users not shown) | |||
Line 1: | Line 1: | ||
{{Short description|Chemical compound}} |
|||
{{Drugbox |
{{Drugbox |
||
| Watchedfields = changed |
|||
| verifiedrevid = |
| verifiedrevid = 451550070 |
||
| IUPAC_name = 3-(5-dipropylaminomethyloxazol-2-yl)-8-fluoro-5-methyl-5,6-dihydro- |
| IUPAC_name = 3-(5-dipropylaminomethyloxazol-2-yl)-8-fluoro-5-methyl-5,6-dihydro-4''H''-imidazo[1,5-''a''][1,4]benzodiazepin-6-one |
||
| image = Ro48-8684_structure.png |
|||
| |
| image = Ro48-8684.svg |
||
| width = 242 |
|||
<!--Clinical data--> |
<!--Clinical data--> |
||
| tradename = |
| tradename = |
||
| legal_status = |
| legal_status = |
||
<!--Pharmacokinetic data--> |
<!--Pharmacokinetic data--> |
||
Line 13: | Line 15: | ||
| metabolism = |
| metabolism = |
||
| elimination_half-life = |
| elimination_half-life = |
||
| excretion = |
| excretion = |
||
<!--Identifiers--> |
<!--Identifiers--> |
||
| CAS_number = 179634-04-9 |
|||
| PubChem = 9866317 |
| PubChem = 9866317 |
||
| ChemSpiderID = 8042008 |
|||
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} |
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} |
||
<!--Chemical data--> |
<!--Chemical data--> |
||
| C=22 | H=26 | F=1 | N=5 | O=2 |
| C=22 | H=26 | F=1 | N=5 | O=2 |
||
| smiles = CCCN(CC1=CN=C(C2=C(CN(C(C3=C4C=CC(F)=C3)=O)C)N4C=N2)O1)CCC |
|||
| molecular_weight = 411.472 |
|||
| StdInChI = 1S/C22H26FN5O2/c1-4-8-27(9-5-2)12-16-11-24-21(30-16)20-19-13-26(3)22(29)17-10-15(23)6-7-18(17)28(19)14-25-20/h6-7,10-11,14H,4-5,8-9,12-13H2,1-3H3 |
|||
| smiles = CCCN(CCC)Cc(cn3)oc3-c2ncn-1c2CN(C)C(=O)c4cc(F)ccc-14 |
|||
| StdInChIKey = YKKLHEHNUYCLQQ-UHFFFAOYSA-N |
|||
}} |
}} |
||
'''Ro48-8684''' is a water-soluble [[benzodiazepine]] derivative developed by [[Hoffman-LaRoche]] in the 1990s, which was designed along with [[Ro48-6791]] as an improved replacement for [[midazolam]], but ultimately proved to have little advantages over the parent drug and has not been introduced into clinical practice.<ref>van Gerven JM, Roncari G, Schoemaker RC, Massarella J, Keesmaat P, Kooyman H, Heizmann P, Zell M, Cohen AF, Dingemanse J |
'''Ro48-8684''' is a water-soluble [[benzodiazepine]] derivative developed by [[Hoffman-LaRoche]] in the 1990s, which was designed along with [[Ro48-6791]] as an improved replacement for [[midazolam]], but ultimately proved to have little advantages over the parent drug and has not been introduced into clinical practice.<ref>{{cite journal | vauthors = van Gerven JM, Roncari G, Schoemaker RC, Massarella J, Keesmaat P, Kooyman H, Heizmann P, Zell M, Cohen AF, Dingemanse J | display-authors = 6 | title = Integrated pharmacokinetics and pharmacodynamics of Ro 48-8684, a new benzodiazepine, in comparison with midazolam during first administration to healthy male subjects | journal = British Journal of Clinical Pharmacology | volume = 44 | issue = 5 | pages = 487–93 | date = November 1997 | pmid = 9384466 | pmc = 2042863 | doi = 10.1046/j.1365-2125.1997.t01-1-00613.x }}</ref><ref>{{cite journal | vauthors = Albrecht S, Hering W, Ihmsen H, Schwilden H, Schüttler J | title = [Pharmacokinetic-pharmacodynamic modeling in phase II of drug development. A comparative study with young and old volunteers with benzdiazepine as an example] | journal = Anästhesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie | volume = 34 | issue = 10 | pages = 634–7 | date = October 1999 | pmid = 10548960 | doi = 10.1055/s-1999-213 }}</ref> |
||
⚫ | |||
⚫ | |||
*[[Benzodiazepine]] |
*[[Benzodiazepine]] |
||
==References== |
== References == |
||
{{reflist}} |
{{reflist}} |
||
{{Benzodiazepines}} |
{{Benzodiazepines}} |
||
{{GABAAR PAMs}} |
|||
[[Category: |
[[Category:Abandoned drugs]] |
||
[[Category: |
[[Category:GABAA receptor positive allosteric modulators]] |
||
[[Category:Drugs developed by Hoffmann-La Roche]] |
|||
[[Category:Imidazobenzodiazepines]] |
[[Category:Imidazobenzodiazepines]] |
||
[[Category:Lactams]] |
[[Category:Lactams]] |
||
[[Category: |
[[Category:Fluoroarenes]] |
||
[[Category: |
[[Category:Oxazoles]] |
||